Shopping Cart
- Remove All
- Your shopping cart is currently empty
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $31 | In Stock | |
5 mg | $50 | In Stock | |
10 mg | $77 | In Stock | |
25 mg | $173 | In Stock | |
50 mg | $273 | In Stock | |
100 mg | $403 | In Stock | |
200 mg | $573 | In Stock | |
1 mL x 10 mM (in DMSO) | $56 | In Stock |
Description | BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl. |
Alias | 2-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1,3-dioxoisoindoline-5-carboxylic acid |
Molecular Weight | 377.35 |
Formula | C20H15N3O5 |
Cas No. | 292870-53-2 |
Smiles | Cc1c(N2C(=O)c3ccc(cc3C2=O)C(O)=O)c(=O)n(-c2ccccc2)n1C |
Relative Density. | 1.512 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 10 mg/mL (26.5 mM), Sonication and heating to 80℃ are recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.